- Release Date: 31/01/18 10:54
- Summary: Starpharma to commence DEP cabazitaxel phase 1/2 trial
- Price Sensitive: Yes
- Download Document 146.38KB
Ann: Starpharma to commence DEP cabazitaxel phase 1/2 trial
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.8¢ |
Change
-0.002(2.00%) |
Mkt cap ! $40.97M | |||
| Open | High | Low | Value | Volume |
| 9.9¢ | 10.0¢ | 9.8¢ | $39.64K | 402.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 824859 | 9.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 221589 | 7 |
View Market Depth
| Last trade - 16.10pm 06/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |